Olema Pharmaceuticals Inc (OLMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Operating Expenses | 142,258 | 104,961 | 106,988 | 71,491 | 21,528 |
| Operating Income | -142,258 | -104,961 | -106,988 | -71,491 | -21,528 |
| Interest Expense | 0 | 0 | 0 | 0 | 653 |
| Other Income | 12,784 | 8,306 | 2,201 | 395 | 60 |
| Pre-tax Income | -129,474 | -96,655 | -104,787 | -71,096 | -22,121 |
| Net Income Continuous | -129,474 | -96,655 | -104,787 | -71,096 | -22,121 |
| Net Income | $-129,474 | $-96,655 | $-104,787 | $-71,096 | $-22,121 |
| EPS Basic Total Ops | -2.20 | -2.14 | -2.62 | -1.80 | -3.42 |
| EPS Basic Continuous Ops | -2.20 | -2.14 | -2.62 | -1.80 | -3.15 |
| EPS Diluted Total Ops | -2.20 | -2.14 | -2.62 | -1.80 | -3.42 |
| EPS Diluted Continuous Ops | -2.20 | -2.14 | -2.62 | -1.80 | -3.15 |
| EPS Diluted Before Non-Recurring Items | -2.20 | -2.14 | -2.62 | -1.80 | -3.42 |
| EBITDA(a) | $-141,865 | $-104,584 | $-106,631 | $-71,052 | $-21,517 |